药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Benzonatate
Dexverapamil
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Sunitinib.
Benzonatate
Penfluridol
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Penfluridol.
Benzonatate
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Dexchlorpheniramine.
Benzonatate
Lorcainide
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Lorcainide.
Benzonatate
Bunaftine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Bunaftine.
Benzonatate
Nizofenone
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Nizofenone.
Benzonatate
Otilonium
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Otilonium.
Benzonatate
Sultopride
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Sultopride.
Benzonatate
Oxatomide
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Oxatomide.
Benzonatate
Abexinostat
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Abexinostat.
Benzonatate
Mizolastine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Mizolastine.
Benzonatate
Ricolinostat
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Ricolinostat.
Benzonatate
Simendan
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Simendan.
Benzonatate
CUDC-101
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with CUDC-101.
Benzonatate
Entinostat
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Entinostat.
Benzonatate
Mocetinostat
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Mocetinostat.
Benzonatate
Amifampridine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Amifampridine.
Benzonatate
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Dexchlorpheniramine maleate.
Benzonatate
Melperone
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Melperone.
Benzonatate
Eperisone
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Eperisone.